Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.

Chun SG, Hu C, Choy H, Komaki RU, Timmerman RD, Schild SE, Bogart JA, Dobelbower MC, Bosch W, Galvin JM, Kavadi VS, Narayan S, Iyengar P, Robinson CG, Wynn RB, Raben A, Augspurger ME, MacRae RM, Paulus R, Bradley JD.

J Clin Oncol. 2017 Jan;35(1):56-62.

PMID:
28034064
2.

Adjuvant Radiation Improves Survival in Older Women Following Breast-Conserving Surgery for Estrogen Receptor-Negative Breast Cancer.

Daugherty EC, Daugherty MR, Bogart JA, Shapiro A.

Clin Breast Cancer. 2016 Dec;16(6):500-506.e2. doi: 10.1016/j.clbc.2016.06.017.

PMID:
27431462
3.

Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).

Salama JK, Gu L, Wang X, Pang HH, Bogart JA, Crawford J, Schild SE, Vokes EE, Ready NE.

J Thorac Oncol. 2016 Mar;11(3):361-9. doi: 10.1016/j.jtho.2015.11.001.

PMID:
26723241
4.

Limited-Stage Small-Cell Lung Cancer: An Age Limit for Combined Modality Therapy?

Bogart JA, Gajra A.

J Clin Oncol. 2015 Dec 20;33(36):4235-7. doi: 10.1200/JCO.2015.64.0888. No abstract available.

PMID:
26503206
5.

Complications from computed tomography-guided core needle biopsy for patients receiving stereotactic body radiation therapy for early-stage lesions of the lung.

Chowdhry VK, Chowdhry AK, Goldman N, Scalzetti EM, Grage RA, Bogart JA.

Clin Lung Cancer. 2014 Jul;15(4):302-6. doi: 10.1016/j.cllc.2014.04.001.

PMID:
24954230
7.

Immunotherapy in non-small-cell lung cancer: a good start?

Bogart JA, Gajra A.

Lancet Oncol. 2014 Jan;15(1):5-6. doi: 10.1016/S1470-2045(13)70572-2. No abstract available.

PMID:
24331155
8.

Radiotherapy for stage III non-small-cell lung carcinoma in the elderly (age ≥ 70 years).

Aridgides PD, Janik A, Bogart JA, Duffy S, Rosenbaum P, Gajra A.

Clin Lung Cancer. 2013 Nov;14(6):674-9. doi: 10.1016/j.cllc.2013.05.001.

PMID:
23891240
9.

A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904.

Salama JK, Hodgson L, Pang H, Urbanic JJ, Blackstock AW, Schild SE, Crawford J, Bogart JA, Vokes EE; Cancer and Leukemia Group B..

J Thorac Oncol. 2013 Aug;8(8):1043-9. doi: 10.1097/JTO.0b013e318293d8a4.

10.

Stereotactic body radiotherapy in patients with stage I non-small-cell lung cancer aged 75 years and older: retrospective results from a multicenter consortium.

Samuels MA, Kandula S, Koru-Sengul T, Bogart JA, Salama JK, Aridgides PD, Gajra A, Lilenbaum RC.

Clin Lung Cancer. 2013 Jul;14(4):446-51. doi: 10.1016/j.cllc.2013.03.004.

PMID:
23660522
11.

Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206.

Kelley MJ, Bogart JA, Hodgson LD, Ansari RH, Atkins JN, Pang H, Green MR, Vokes EE.

J Thorac Oncol. 2013 Jan;8(1):102-8. doi: 10.1097/JTO.0b013e31827628e1.

12.

Novel approaches of chemoradiotherapy in unresectable stage IIIA and stage IIIB non-small cell lung cancer.

Stinchcombe TE, Bogart JA.

Oncologist. 2012;17(5):682-93. doi: 10.1634/theoncologist.2012-0020. Review.

13.

Thoracic radiotherapy for limited stage small cell lung carcinoma.

Aridgides PD, Movsas B, Bogart JA.

Curr Probl Cancer. 2012 May-Jun;36(3):88-105. doi: 10.1016/j.currproblcancer.2012.03.001. Review. No abstract available.

PMID:
22495055
14.

Split-course radiotherapy for poor-risk stage III lung cancer: striking the right balance or history regurgitated?

Bogart JA.

J Thorac Oncol. 2011 Jun;6(6):975-7. doi: 10.1097/JTO.0b013e31821c0a53. No abstract available.

15.

Pulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of Cancer and Leukemia Group B (CALGB) trial 30105.

Salama JK, Stinchcombe TE, Gu L, Wang X, Morano K, Bogart JA, Crawford JC, Socinski MA, Blackstock AW, Vokes EE; Cancer and Leukemia Group B..

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e269-74. doi: 10.1016/j.ijrobp.2011.01.056.

16.

Fractionated radiotherapy for high-risk patients with early-stage non-small cell lung cancer.

Bogart JA.

Semin Thorac Cardiovasc Surg. 2010 Spring;22(1):44-52. doi: 10.1053/j.semtcvs.2010.04.006. Review.

PMID:
20813316
17.

Stereotactic body radiation therapy for early-stage lung cancer: are we "all in".

Bogart JA.

J Thorac Oncol. 2010 Jul;5(7):927-9. doi: 10.1097/JTO.0b013e3181e3a319. No abstract available.

18.

Radiation therapy-related toxicity (including pneumonitis and fibrosis).

Chopra RR, Bogart JA.

Hematol Oncol Clin North Am. 2010 Jun;24(3):625-42. doi: 10.1016/j.hoc.2010.03.009.

PMID:
20488358
19.

Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904.

Bogart JA, Hodgson L, Seagren SL, Blackstock AW, Wang X, Lenox R, Turrisi AT 3rd, Reilly J, Gajra A, Vokes EE, Green MR.

J Clin Oncol. 2010 Jan 10;28(2):202-6. doi: 10.1200/JCO.2009.25.0753.

20.

Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials.

Powell JW, Dexter E, Scalzetti EM, Bogart JA.

Lancet Oncol. 2009 Sep;10(9):885-94. doi: 10.1016/S1470-2045(09)70103-2. Review.

PMID:
19717090
Items per page

Supplemental Content

Loading ...
Support Center